<p><i>(A) MIA PaCa-2 and (B) PANC-1 cells were exposed to graded concentrations of Betulinic acid, Thymoquinone or Gemcitabine either alone or in combination at a fixed dose ratio of Betulinic acid vs. Gemcitabine and Thymoquinone vs. Gemcitabine for 48 hrs.(Gemcitabine</i><i>having exposure for 24 hrs only in case of combination), Gemcitabine (squares),</i><i>Betulinic acid and Thymoquinone</i><i>(circle) Gemcitabine+ betulinic acid and Gemcitabine +Thymoquinone (triangle).(Mono therapy (BA, GCB, TQ) Versus Combinations(CI<sub>(GCB:BA)</sub>, CI<sub>(GCB:TQ)</sub>)(**, significant difference at p value <0.01, n = 3).</i></p
<p>(A) KAN0439834 in PaCa-2 cell line was significantly more effective compared to gemcitabine (p = ...
Pancreatic adenocarcinoma is a common disease considered to be poorly responsive to antiblastic trea...
<p>A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...
<div><p>Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures i...
Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures in many i...
<p><i>IC<sub>50</sub></i><i>value was calculated on</i><i>Human pancreas adenocarcinoma</i><i>cell l...
<p><i>(A and B) Showing isolobolograms analysis of the combination of gemcitabine, Betulinic acid or...
<p>(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...
<p><i>(A) MIA PaCa-2 cells treated with Betulinic acid, Thymoquinone and Gemcitabine alone and in co...
Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...
Although the recently-developed Gemcitabine (GEM) has renewed interest in clinical research in pancr...
Background: gamma-Linolenic acid (GLA) is growth inhibitory both in vitro and in vivo, at doses non-...
In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in a...
International audienceThe use of chemotherapy drugs before or after surgery is common in human pancr...
Gemcitabine (GEM) is a cell-cycle specific inhibitor of DNA synthesis and repair, and has been appli...
<p>(A) KAN0439834 in PaCa-2 cell line was significantly more effective compared to gemcitabine (p = ...
Pancreatic adenocarcinoma is a common disease considered to be poorly responsive to antiblastic trea...
<p>A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...
<div><p>Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures i...
Gemcitabine, an effective agent in treatment of cancer of pancreas, has undergone failures in many i...
<p><i>IC<sub>50</sub></i><i>value was calculated on</i><i>Human pancreas adenocarcinoma</i><i>cell l...
<p><i>(A and B) Showing isolobolograms analysis of the combination of gemcitabine, Betulinic acid or...
<p>(A) AsPC-1, BxPC-3, and COLO-357 cells were incubated for 48 h in the absence or presence of vary...
<p><i>(A) MIA PaCa-2 cells treated with Betulinic acid, Thymoquinone and Gemcitabine alone and in co...
Pancreatic cancer cell lines BxPC-3 (A), Capan-2 (B), MIA PaCa-2 (C), PANC-1 (D), and Hs766T (E) wer...
Although the recently-developed Gemcitabine (GEM) has renewed interest in clinical research in pancr...
Background: gamma-Linolenic acid (GLA) is growth inhibitory both in vitro and in vivo, at doses non-...
In a randomized clinical trial, gemcitabine (GEM) was more effective than 5-fluorouracil (5-FU) in a...
International audienceThe use of chemotherapy drugs before or after surgery is common in human pancr...
Gemcitabine (GEM) is a cell-cycle specific inhibitor of DNA synthesis and repair, and has been appli...
<p>(A) KAN0439834 in PaCa-2 cell line was significantly more effective compared to gemcitabine (p = ...
Pancreatic adenocarcinoma is a common disease considered to be poorly responsive to antiblastic trea...
<p>A. All cancerous cell lines excluding the normal HPDE are DZNep-responsive and reduced cellular v...